TD Cowen lowered the firm’s price target on Aspen Aerogels (ASPN) to $9 from $11 and keeps a Buy rating on the shares. Soft Q1 results and Q2 guidance turn “2025 into a transition year on further EV production weakness,” the analyst tells investors. However, the firm’s one to three year U.S. EV demand view is “still more constructive than consensus” and while it is reducing estimates it still likes the risk/reward post pullback, the analyst added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels price target lowered to $10 from $22 at B. Riley
- Aspen Aerogels price target lowered to $8 from $16 at Roth Capital
- Aspen Aerogels Faces Challenges Amid New Contract Win
- Aspen Aerogels Navigates Challenges in Earnings Call
- Aspen Aerogels downgraded to Perform at Oppenheimer on deteriorating demand